MAPT and dementia: For this reason, it may be regarded as a valuable adjuvant tool to other methods with confirmed efficacy in dementia such as amyloid positron emission tomography (amyloid-PET) [137] or assessment of levels of amyloid-beta1-42 and tau protein in cerebrospinal fluid [138].